These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study. Burkart DJ; Borsa JJ; Anthony JP; Thurlo SR J Vasc Interv Radiol; 2003 Jun; 14(6):729-33. PubMed ID: 12817039 [TBL] [Abstract][Full Text] [Related]
3. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520 [TBL] [Abstract][Full Text] [Related]
4. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis. Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257 [TBL] [Abstract][Full Text] [Related]
5. Thrombolysis of occluded peripheral arteries and veins with tenecteplase: a pilot study. Burkart DJ; Borsa JJ; Anthony JP; Thurlo SR J Vasc Interv Radiol; 2002 Nov; 13(11):1099-102. PubMed ID: 12427808 [TBL] [Abstract][Full Text] [Related]
6. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients. Kim HS; Preece SR; Black JH; Pham LD; Streiff MB J Vasc Surg; 2008 Feb; 47(2):388-94. PubMed ID: 18241762 [TBL] [Abstract][Full Text] [Related]
7. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study. Castaneda F; Li R; Young K; Swischuk JL; Smouse B; Brady T J Vasc Interv Radiol; 2002 Jun; 13(6):577-80. PubMed ID: 12050297 [TBL] [Abstract][Full Text] [Related]
8. Catheter-directed thrombolysis for the management of postpartum deep venous thrombosis. Acharya G; Singh K; Hansen JB; Kumar S; Maltau JM Acta Obstet Gynecol Scand; 2005 Feb; 84(2):155-8. PubMed ID: 15683376 [TBL] [Abstract][Full Text] [Related]
9. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684 [TBL] [Abstract][Full Text] [Related]
10. Reteplase: nursing implications for catheter-directed thrombolytic therapy for peripheral vascular occlusions. Bussard ME Crit Care Nurse; 2002 Jun; 22(3):57-63. PubMed ID: 12092294 [TBL] [Abstract][Full Text] [Related]
11. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study. Drescher P; Crain MR; Rilling WS J Vasc Interv Radiol; 2002 Jan; 13(1):37-43. PubMed ID: 11788692 [TBL] [Abstract][Full Text] [Related]
12. Tenecteplase in acute lower-leg ischemia: efficacy, dose, and adverse events. Hull JE; Hull MK; Urso JA; Park HA J Vasc Interv Radiol; 2006 Apr; 17(4):629-36. PubMed ID: 16614145 [TBL] [Abstract][Full Text] [Related]